| Zugriffe | |
|---|---|
| Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study | 88 |
| Juli 2024 | August 2024 | September 2024 | Oktober 2024 | November 2024 | Dezember 2024 | Januar 2025 | |
|---|---|---|---|---|---|---|---|
| Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study | 5 | 8 | 0 | 1 | 1 | 3 | 0 |
| Zugriffe | |
|---|---|
| 2020_Belyavskiy_etal.pdf | 71 |
